MedElevator
Войти в исследования Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2009
[Expression of maspin and its relation to tumor vascularization in epithelian ovarian cancer].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ma Ying, Peng Zhi-lan
Аннотация
OBJECTIVE: To investigate the correlation of Maspin expression with angiogenesis in ovarian cancer.
METHODS: The expression of Maspin, VEGF, heparanase gene was detected by immunohistochemistry in formalin-fixed, paraffin-embedded specimens of normal ovaries (n=31) and epithelial ovarian cancers (n=35). Correlations of Maspin, VEGF and heparanase expression with clinicopathological parameters of ovarian tumors were statistically analyzed. Microvessel density (MVD) was counted by endothelial cells immunostained with anti-CD34 monoclonal antibody.
RESULTS: The expression of Maspin, VEGF, heparanase protein were up-regulated in ovarian cancer cells compared with control group (P < 0.05). Significant association was observed in Maspin protein expression and clinical parameters such as non-serous ovarian carcinoma, lower tumor stage and non-ascites (P < 0. 05). VEGF protein expression correlated with ascites positively (P < 0.05). Heparanase protein expression was identified obviously to correlate with lymph node involvement and ascites (P < 0.05). MVD has significant correlation with lymph node involvement and tumor stage (P < 0.05). Maspin protein expression correlated negatively with VEGF and MVD(P < 0.05), but had no relationship with heparanase (P > 0.05). Significant direct association was demonstrated between VEGF protein expression and MVD (P < 0.05), but VEGF protein expression had no correlation with heparanase.
CONCLUSION: Maspin might have inhibitory effects on invasion and metastasis of epithelian ovarian cancer.
METHODS: The expression of Maspin, VEGF, heparanase gene was detected by immunohistochemistry in formalin-fixed, paraffin-embedded specimens of normal ovaries (n=31) and epithelial ovarian cancers (n=35). Correlations of Maspin, VEGF and heparanase expression with clinicopathological parameters of ovarian tumors were statistically analyzed. Microvessel density (MVD) was counted by endothelial cells immunostained with anti-CD34 monoclonal antibody.
RESULTS: The expression of Maspin, VEGF, heparanase protein were up-regulated in ovarian cancer cells compared with control group (P < 0.05). Significant association was observed in Maspin protein expression and clinical parameters such as non-serous ovarian carcinoma, lower tumor stage and non-ascites (P < 0. 05). VEGF protein expression correlated with ascites positively (P < 0.05). Heparanase protein expression was identified obviously to correlate with lymph node involvement and ascites (P < 0.05). MVD has significant correlation with lymph node involvement and tumor stage (P < 0.05). Maspin protein expression correlated negatively with VEGF and MVD(P < 0.05), but had no relationship with heparanase (P > 0.05). Significant direct association was demonstrated between VEGF protein expression and MVD (P < 0.05), but VEGF protein expression had no correlation with heparanase.
CONCLUSION: Maspin might have inhibitory effects on invasion and metastasis of epithelian ovarian cancer.